Circulating microparticles carry oxidation-specific epitopes and are recognized by natural IgM antibodies. - Wikidata - wikimedia - TriplyDB

Circulating microparticles carry oxidation-specific epitopes and are recognized by natural IgM antibodies.

Circulating microparticles carry oxidation-specific epitopes and are recognized by natural IgM antibodies.

http://www.wikidata.org/entity/Q35014306

about

Roles of antibody against oxygenized low density lipoprotein in atherosclerosis: recent advances The effect of oxidized phospholipids on phenotypic polarization and function of macrophages.Extracellular vesicles in cardiovascular disease: are they Jedi or Sith?European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS).Secreted IgM deficiency leads to increased BCR signaling that results in abnormal splenic B cell development.Low levels of IgM antibodies recognizing oxidation-specific epitopes are associated with human non-alcoholic fatty liver disease.Soluble IgM links apoptosis to complement activation in early alcoholic liver disease in mice.High Serum Immunoglobulin G and M Levels Predict Freedom From Adverse Cardiovascular Events in Hypertension: A Nested Case-Control Substudy of the Anglo-Scandinavian Cardiac Outcomes Trial The association between oxidized low-density lipoprotein antibodies and hematological diseases.Senescent cells expose and secrete an oxidized form of membrane-bound vimentin as revealed by a natural polyreactive antibody.Extracellular vesicles and atherosclerotic disease.Readapting the adaptive immune response - therapeutic strategies for atherosclerosis.Clinical Use and Therapeutic Potential of IVIG/SCIG, Plasma-Derived IgA or IgM, and Other Alternative Immunoglobulin Preparations.Malondialdehyde Epitopes as Targets of Immunity and the Implications for Atherosclerosis.Innate sensing of oxidation-specific epitopes in health and disease.Transplantation and Damage-Associated Molecular Patterns (DAMPs).Malondialdehyde epitopes are sterile mediators of hepatic inflammation in hypercholesterolemic mice.Extracellular vesicles in coronary artery disease.Sialic Acid-Binding Immunoglobulin-like Lectin G Promotes Atherosclerosis and Liver Inflammation by Suppressing the Protective Functions of B-1 Cells.Perivascular Adipose Tissue Harbors Atheroprotective IgM-Producing B Cells.Cultivation and Immortalization of Human B-Cells Producing a Human Monoclonal IgM Antibody Binding to MDA-LDL: Further Evidence for Formation of Atherogenic MDA-LDL Adducts in Humans In Vivo.Natural regulatory IgM-mediated autoimmune responses directed against malondialdehyde regulate oxidative and nitrosative pathways and coupled with IgM responses to nitroso adducts attenuate depressive and physiosomatic symptoms at the end of term pr Massively Parallel Sequencing of Peritoneal and Splenic B Cell Repertoires Highlights Unique Properties of B-1 Cell Antibodies.Applicability of extracellular vesicles in clinical studies.PET/MR Imaging of Malondialdehyde-Acetaldehyde Epitopes With a Human Antibody Detects Clinically Relevant Atherothrombosis.NHLBI Working Group Recommendations to Reduce Lipoprotein(a)-Mediated Risk of Cardiovascular Disease and Aortic Stenosis.Natural antibodies to oxidation-specific epitopes: innate immune response and venous thromboembolic disease.The Neutrophil's Choice: Phagocytose vs Make Neutrophil Extracellular Traps.Characterization of Natural IgM Antibodies Recognizing Oxidation-Specific Epitopes on Circulating Microvesicles.Oxidation-specific epitopes restrain bone formation.Complement Activation in Liver Transplantation: Role of Donor Macrosteatosis and Implications in Delayed Graft Function.Oxidized phospholipids are proinflammatory and proatherogenic in hypercholesterolaemic mice

P2860

Q26778507-D96A5259-8004-4D09-8572-4DDF54C12D4E Q30268532-E1D6C7FC-8922-46BC-B442-C5D8FD9A0605 Q33362561-B073DC18-EA2E-4154-B452-0DA52EC077EF Q33761211-06897387-77D5-4897-B29A-84611B7E121F Q33799269-FEF6413A-EEDA-47DA-8633-0D0D4CAB7295 Q36083468-83015263-B021-46E2-92E1-E842E34E5515 Q36788663-516A3D5A-A878-4057-8AEF-1872C40AEB2D Q37149945-D3E619B3-5386-467C-9904-BDDE57823D2B Q37403038-7942A7BC-51D3-4CB7-8437-11393E4F5684 Q37682418-C7E4A2EF-FDB9-4B80-8AB3-F5A7F9369269 Q38430673-37DBAD19-7488-450C-AD1A-CAD2397E3BB5 Q38774904-216F2CB1-D3CE-4996-83E2-79AED4748911 Q38820288-7AF180CB-EC4E-488B-B03F-3BECB996654C Q38846881-0303659A-106E-46CC-BE18-2F66027A652E Q38877941-A3AA4D8F-82A9-4DD1-9D96-45BBC4FD090F Q38898214-ED63E2CD-5041-41BC-B4B9-3417076C20EF Q39096019-71AA05F4-912B-46D3-ACEF-C9C4084B54C2 Q39115035-84BB94CB-F3E7-4D8E-A5DF-96F3EC344E0F Q39309555-0D5DE463-FD94-49EE-B4A7-71E9DA5D2FE8 Q41899674-FE15F392-5586-4E91-93E8-5C63EB4535A2 Q47241498-04202BC2-B4D1-4068-BE1B-4747131D6E9B Q47342024-91C53A07-3DC7-4387-A7EE-6DEDA2DD5EFC Q48147788-49EF9ACB-C82E-4217-90EE-39E28DA270F3 Q48280242-3CBF30D5-9ADB-40FD-9373-E70E50335A82 Q49955253-00C6DA5C-6710-4221-AA7F-030AF03A9FAC Q50081201-74F24B74-C734-4255-BCF0-C69F5401BF6A Q50088353-7F44A0AD-C32D-4E87-9F06-9EB0B091970F Q52668322-8046CD3F-F5BC-4015-8541-25EF65DA03E2 Q53477651-BBF486C3-B4E2-4F13-AB9D-6BFF0B3967B5 Q55238725-7ABADD53-D9F9-4BCD-A07E-32119F41CEB1 Q55711128-C8EE8C4B-97B9-47A0-8CD8-F9926B372C98 Q59066080-3E13A10D-87DF-487E-B10A-FAC0AEEA84A0

P2860

Circulating microparticles carry oxidation-specific epitopes and are recognized by natural IgM antibodies.

http://www.wikidata.org/entity/Q35014306

description

2014 nî lūn-bûn

@nan

2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Circulating microparticles car ...... zed by natural IgM antibodies.

@ast

Circulating microparticles car ...... zed by natural IgM antibodies.

@en

type

label

Circulating microparticles car ...... zed by natural IgM antibodies.

@ast

Circulating microparticles car ...... zed by natural IgM antibodies.

@en

prefLabel

Circulating microparticles car ...... zed by natural IgM antibodies.

@ast

Circulating microparticles car ...... zed by natural IgM antibodies.

@en

P1433

Q35014306-44DB356B-A6CE-4594-939A-2C8F81D6894D

P1476

Q35014306-C9C54387-F20C-4B67-AD2B-53745D7E4349

P2093

Q35014306-39F09E39-C3EC-4C52-8858-276D4973DF25

Q35014306-64A7BC2F-0469-4FA1-9163-9E80FF6FB80C

Q35014306-6ACA5078-50B0-4C68-B289-12CF8DB85A76

Q35014306-77F85348-86EC-4344-B587-E0377B3DA854

Q35014306-84359018-2A13-4C8C-9413-ECB47C0E4001

Q35014306-8A276069-FD1C-418B-A9BC-D1BE82ABC535

Q35014306-983054F5-DEB8-4A2F-98DF-B5571F69E055

Q35014306-9C046B29-6AFD-42A1-8499-C648E65A12B0

Q35014306-E0ED1556-CF10-40DF-A5DA-2F8679A3F333

Q35014306-FDC3919C-79B3-49C5-9507-E89719722268

P2860

Q35014306-0912C49F-7770-4DD2-833C-5AE87D6FCEC0

Q35014306-0BE5C8A4-C32B-44FF-8600-11848AA0409E

Q35014306-0E2B9AA5-874A-49CF-AAEE-FB93DC7EC044

Q35014306-18AFB5E5-9079-480E-9AB6-91BA28E8631F

Q35014306-1F464213-F76E-4AE7-B497-FF8CECF99F75

Q35014306-20881CF3-943B-4544-B329-AC399892DA99

Q35014306-290542D6-66B3-45C1-B952-91AA58CABC25

Q35014306-336253E5-5D6E-4556-9C51-2E5AB734A766

Q35014306-36EA4095-96E8-4187-B12F-6456111BAC0D

Q35014306-37F0B767-921F-402C-936B-C6BDD1B29B92

P304

Q35014306-3EB9A307-05E6-41A2-9B49-CDCA29800069

P31

Q35014306-5921BB91-195E-4326-ACF8-185323F663DB

P356

Q35014306-811F6C26-7110-455C-B1B1-0A0DD20EF25D

P433

Q35014306-DBC48A23-7473-4B9D-8C0C-89C34E3B6DBF

P478

Q35014306-9E5F8FEB-DDAD-4BF7-B858-4F9F99269B04

P50

Q35014306-193244A3-696A-4E17-972A-67952DA24449

Q35014306-45A566B7-35CD-43F9-B6D5-0E32ADCA095D

Q35014306-50C95809-B043-4919-AE57-CC6AEBE51586

Q35014306-91F31AE3-47EA-4738-82EB-13809050B681

Q35014306-C351037D-5694-4E53-B157-5BA4D26CB509

P577

Q35014306-C22AE9DC-5994-48C9-B643-562CF975F2CE

P698

Q35014306-43F5CBAA-7768-45C6-8B90-F87EFEABE3D7

P932

Q35014306-4AFBCCD6-3DA9-4F06-97AD-BC988C3AE9FB

P356

P1433

Journal of Lipid Research

P1476

Circulating microparticles car ...... zed by natural IgM antibodies.

@en

P2093

Caroline Bartel

http://www.w3.org/2001/XMLSchema#string

Dimitrios Tsiantoulas

http://www.w3.org/2001/XMLSchema#string

Irene M Lang

http://www.w3.org/2001/XMLSchema#string

Joseph L Witztum

http://www.w3.org/2001/XMLSchema#string

Michael B Fischer

http://www.w3.org/2001/XMLSchema#string

Nikolina Papac-Milicevic

http://www.w3.org/2001/XMLSchema#string

Sohvi Hörkkö

http://www.w3.org/2001/XMLSchema#string

Sotirios Tsimikas

http://www.w3.org/2001/XMLSchema#string

Taras Afonyushkin

http://www.w3.org/2001/XMLSchema#string

Thomas A Prohaska

http://www.w3.org/2001/XMLSchema#string

P2860

Microparticles, vascular function, and atherothrombosis

Cholesterol-induced membrane microvesicles as novel carriers of damage-associated molecular patterns: mechanisms of formation, action, and detoxification.

B cells and humoral immunity in atherosclerosis

Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins.

Resolution of prostaglandin endoperoxide synthase and thromboxane synthase of human platelets.

Oxidative damage in multiple sclerosis lesions.

Microparticles in hemostasis and thrombosis.

Monocytic microparticles activate endothelial cells in an IL-1β-dependent manner.

Peptide mimotopes of malondialdehyde epitopes for clinical applications in cardiovascular disease.

Release and capture of bioactive oxidized phospholipids and oxidized cholesteryl esters during percutaneous coronary and peripheral arterial interventions in humans.

P304

440-448

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1194/JLR.P054569

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

56

http://www.w3.org/2001/XMLSchema#string

P50

Chantal M Boulanger

Thomas Perkmann

Christoph J Binder

Vincent Millischer

Andreas Mangold

P577

2014-12-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25525116

http://www.w3.org/2001/XMLSchema#string

P932

4306697

http://www.w3.org/2001/XMLSchema#string